News | March 22, 2022
Barentz acquires life science ingredients, specialty chemicals distributor Divsa
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Divsa's coverage across Central America bridges Barentz' leading positions in North and South America
Building the future of food in the birthplace of cell-cultured milk
The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia
Enables millions of Indians to monitor their vitals without the need of any additional device
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
The company plans to launch the product immediately
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Subscribe To Our Newsletter & Stay Updated
